Color Doppler ultrasound in benign and malignant breast tumors

Citation
Tc. Chao et al., Color Doppler ultrasound in benign and malignant breast tumors, BREAST CANC, 57(2), 1999, pp. 193-199
Citations number
22
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
BREAST CANCER RESEARCH AND TREATMENT
ISSN journal
01676806 → ACNP
Volume
57
Issue
2
Year of publication
1999
Pages
193 - 199
Database
ISI
SICI code
0167-6806(199909)57:2<193:CDUIBA>2.0.ZU;2-E
Abstract
To study the flow indices of color Doppler ultrasound in the differentiatio n of malignant and benign breast tumors, data of 1124 female patients with breast lesions were analyzed. Of 1124 breast lesions, 590 (525%) were benig n and 534 (47.5%) were malignant. Color Doppler scanning detected vasculari ty in 505 (85.6%) of benign lesions and 509 (95.3%) of malignant tumors. Th e tumors without detectable vascularization (1.9 +/- 0.1 cm) were significa ntly (p < 0.0001) smaller than the tumors with vascularization (2.7 +/- 0.1 cm). The age of the patients with malignant tumors was older than that of the patients with benign lesions. The size of malignant tumors was signific antly larger than that of benign lesions. Significantly higher values of ve ssel number, resistance index (RI), pulsatility index (PI), and systolic pe ak flow velocity (V-max) were found in carcinomas but the striking overlap of the values did not allow defining cutoff values which allow an accurate differentiation. V-max did not correlate with the size of tumors. When tumo rs were grouped as T1 (2 cm or less), T2 (> 2 cm, but not > 5 cm), and T3 ( > 5 cm), the results were similar to those of all breast tumors. In conclus ion, number of vessels, RI, PI, and V-max do not provide accurate different iation of benign and malignant tumors. However, average values of these flo w indices of malignant tumors were significantly larger than those of benig n lesions. Tumors with larger values of vessel number, RI, PI or V-max requ ire further studies to disclose the possibility of malignant tumors.